We are live on ! Find out more
RGEN icon

Repligen

184 hedge funds and large institutions have $995M invested in Repligen in 2016 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 64 increasing their positions, 60 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

159% more call options, than puts

Call options by funds: $8.21M | Put options by funds: $3.17M

95.37% more ownership

Funds ownership: 0%95.37% (+95%)

37% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 19

1% more funds holding

Funds holding: 182184 (+2)

7% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 60

3% more capital invested

Capital invested by funds: $963M → $995M (+$31.6M)

Holders
184
Holders Change
+2
Holders Change %
+1.1%
% of All Funds
4.59%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
26
Increased
64
Reduced
60
Closed
19
Calls
$8.21M
Puts
$3.17M
Net Calls
+$5.04M
Net Calls Change
+$6.77M

RGEN Hedge Fund Activity: Q4 2016 in Review

184 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q4 2016, worth a combined $995M — up 3.3% from $963M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new RGEN positions and 19 closed out — a net gain of 7 holders — while 64 added to existing stakes and 60 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $10.4M. The largest seller was Fidelity Investments, cutting an estimated $8.56M.

  • 184 institutional investors held Repligen (RGEN) as of Q4 2016, up from 182 in Q3 2016.
  • Funds reported $995M of Repligen stock for Q4 2016, up 3.3% quarter-over-quarter.
  • 26 funds opened new Repligen positions in Q4 2016 and 19 closed out, a net change of +7 holders.
  • The largest Repligen buyer in Q4 2016 was BlackRock Fund Advisors, an estimated $10.4M added.
  • The largest Repligen seller in Q4 2016 was Fidelity Investments, an estimated $8.56M sold.

Based on aggregated 13F filings for Q4 2016.